Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
10/2012
10/25/2012US20120270943 D-aspartic Acid Pro-nutrients with Improved Solubility Characteristics
10/25/2012US20120270893 Substituted acetyl-coa carboxylase inhibitors
10/25/2012US20120270876 Treatment of Conditions Through Pharmacological Modulation of the Autonomic Nervous System
10/25/2012US20120270838 Spiroimidazolone derivative
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270784 Growth hormone releasing factor (grf) analogs and uses thereof
10/25/2012US20120270782 Formulation for hgh and rhigf-1 combination
10/25/2012US20120269865 Nutritional composition for promoting gut microbiota balance and health
10/25/2012US20120269838 Carrier conjugates of il-23-peptides and their induced antibodies
10/25/2012US20120269796 Method for Enhancing Pancreatic Beta Cell Proliferation, Increasing Serum Insulin Concentration, Decreasing Blood Glucose Concentration And Treating And/Or Preventing Diabetes
10/25/2012US20120269793 Phytoestrogenic formulations for alleviation or prevention of hair loss
10/25/2012US20120269772 Lipid depot formulations
10/24/2012EP2514745A1 GPR120 receptor agonists and uses thereof
10/24/2012EP2513087A1 Tetrazole derivatives as nicotinic acetylcholine receptor moudlators
10/24/2012EP2513072A1 Pyrazine derivatives,process for manufacture and use thereof
10/24/2012EP2513070A1 Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
10/24/2012CN202497471U Progestogen tampon for animals
10/24/2012CN102753565A Progesterone receptor antagonists
10/24/2012CN102753557A Salt of fused heterocyclic derivative and crystal thereof
10/24/2012CN102753539A Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
10/24/2012CN102746220A Novel pyridine alkaloids, preparation process thereof, and the uses of the pyridine alkaloids
10/24/2012CN102743660A Chinese herbal tea and preparation method thereof
10/24/2012CN102743548A Application of airpotato yam rhizome in preparation of medicaments for treating thyroid and tincture
10/24/2012CN102743393A Medicinal composition containing abiraterone acetate and preparation technology thereof
10/24/2012CN102743385A Modulators of atp-binding cassette-transporters
10/24/2012CN102743368A Compounds for the treatment of metabolic disorders
10/24/2012CN102743329A Novel intrauterine sustained control release drug delivery system and preparation method thereof
10/24/2012CN102051322B Jujube mixed liquor and production technology thereof
10/24/2012CN101744852B Preparation method of acanthopanax effervescent tablet and products thereof
10/24/2012CN101088487B polycondensate, preparation method thereof, cosmetic or drug composition, and use thereof
10/23/2012US8293223 Treatment of organ injuries and burns using placental stem cells
10/23/2012CA2706180C Novel glucocorticoid receptor agonists
10/23/2012CA2488635C Antagonists of melanin concentrating hormone receptor
10/23/2012CA2454275C Conformationally constrained parathyroid hormone (pth) analogs
10/23/2012CA2384978C Udp-n-acetylglucosamine: galactose-.beta.1,3-n-acetylgalactosamine-.alpha.-r/(glcnac to galnac) .beta.1,6-n-acetylglucosaminyltransferase, c2gnt3
10/23/2012CA2359840C Glycosylated leptin compositions and related methods
10/18/2012US20120264821 Use of equol for treating androgen mediated diseases
10/18/2012US20120264812 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
10/18/2012US20120264790 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
10/18/2012US20120264777 Oxadiazole beta carboline derivatives as antidiabetic compounds
10/18/2012US20120264716 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264715 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264698 Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions
10/18/2012US20120264691 Medical compositions containing ghrelin
10/18/2012US20120263765 Agents from cells
10/18/2012US20120263695 Composition having strains of lactobacillus fermentum
10/18/2012US20120263679 Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
10/17/2012EP2510007A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012EP2510006A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012EP2510005A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012EP2510004A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012EP2510003A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012EP2510002A1 Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012CN102741291A Neutralizing prolactin receptor antibodies and their therapeutic use
10/17/2012CN102741268A Pyrrolidine derivatives
10/17/2012CN102740860A Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
10/17/2012CN102731499A Lactam compounds and their use as pharmaceuticals
10/17/2012CN102727688A Application of Chinagreen herb in preparation of medicament for treating thyroid and tincture
10/17/2012CN102727548A New technology and method for extracting ginseng stem and leaf total saponin
10/17/2012CN102727482A Daidzein-hydroxypropyl-beta-cyclodextrin clathrate and its preparation method
10/17/2012CN101854954B A methods for preparing the clathrate compound of steroid medicines utilizing hydrotalcite as carrier
10/16/2012US8288537 Caspase inhibitors and uses thereof
10/16/2012US8288342 Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
10/16/2012CA2594171C 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
10/16/2012CA2555571C Differentiation of stem cells to endoderm and pancreatic lineage
10/16/2012CA2485681C Ccr9 inhibitors and methods of use thereof
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/11/2012WO2012136772A1 Fused pyrrole derivates as estrogen receptor ligands
10/11/2012US20120258967 Pi3 kinase inhibitors and uses thereof
10/11/2012US20120258959 Pyridone gpr119 g protein-coupled receptor agonists
10/11/2012US20120258080 Pyridopyrazine derivatives and their use
10/11/2012US20120258069 Rgd-binding compounds and methods of use
10/10/2012EP2506865A2 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
10/10/2012CN1304450B Novel insulin analogs with enhanced zinc binding
10/10/2012CN102725291A Bicyclic pyridines and analogs as sirtuin modulators
10/10/2012CN102719397A Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus)
10/10/2012CN102716420A Medicament for treating cyclomastopathy and hyperprolactinemia and preparation method of medicament
10/10/2012CN102716313A Anti-dairy cow transport stress pharmaceutical composition
10/10/2012CN102716091A Method for preparing metoprolol tartrate particles
10/10/2012CN102018688B PTP1B inhibitor and synthesis and application thereof in preparation of medicine used for treating type II diabetes
10/10/2012CN101857636B Anti-interferon-alpha antibodies
10/10/2012CN101491681B Medicine containing PEG human growth hormone conjugate and use thereof
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101309704B Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
10/09/2012CA2533845C Pharmaceutical compositions comprising insulin sensitivity enhancer and another antidiabetic
10/09/2012CA2451047C Use of picropodophyllin derivatives for treatment of igf-1r mediated disorders
10/09/2012CA2403501C Non-invasive gene targeting to the brain
10/09/2012CA2243845C Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
10/04/2012WO2012134446A1 Epiandrosterone and/or androsterone derivatives and method of use thereof
10/04/2012WO2012133509A1 Novel benzimidazole derivative
10/04/2012US20120252817 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252783 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
10/04/2012US20120252782 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
10/04/2012US20120252772 Cucurbitane-Triterpenoid Compounds, Pharmaceutical Composition, Use and Preparation Method Thereof
10/04/2012US20120252771 Implants and methods for treating inflammation-mediated conditions of the eye
10/04/2012US20120252769 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120251566 Saponin adjuvant compositions and methods relating thereto
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 290